Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 11.59MWorking Capital
VS
Market
Sector
Industry
History
$ 0.8Close
$ 0.58 - $ 1.87 52-Week Range
Ticker Information
Ticker
CUECompany Name
CUE BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCUE BIOPHARMA INC - Working Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CUE - Working Capital Historical data
| Date | Current Assets | Current Liabilities | Working Capital |
|---|---|---|---|
| 6/30/2025 | $ 30.84M | $ 19.25M | $ 11.59M |
| 3/31/2025 | $ 15.93M | $ 15.5M | $ 433K |
| 12/31/2024 | $ 25.14M | $ 13.69M | $ 11.45M |
| 9/30/2024 | $ 37.26M | $ 16.79M | $ 20.47M |
| 6/30/2024 | $ 33.9M | $ 16.46M | $ 17.44M |
| 3/31/2024 | $ 44.67M | $ 18.09M | $ 26.58M |
| 12/31/2023 | $ 51.45M | $ 17.08M | $ 34.37M |
| 9/30/2023 | $ 57.52M | $ 17.21M | $ 40.31M |
| 6/30/2023 | $ 60.94M | $ 16.31M | $ 44.63M |
| 3/31/2023 | $ 68.75M | $ 13.81M | $ 54.95M |
Key Performance Insights, Last 5 Years
- CUE BIOPHARMA INC's latest trailing twelve months (TTM) Working Capital stands at $ 79.34M.
- Over the past 5 years, CUE BIOPHARMA INC's average Working Capital has been $ 44.47M.
- The median Working Capital for CUE BIOPHARMA INC during this period was $ 53.19M
- CUE BIOPHARMA INC reached its highest Working Capital over the past 5 years at $ 79.34M.
- The lowest Working Capital recorded by CUE BIOPHARMA INC in the same timeframe $ 433K
CUE BIOPHARMA INC's Working Capital vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Working Capital Benchmarks
Similar metrics to Working Capital:
- Current Ratio - [Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
- Quick Ratio - [Calculation] The quick ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations without the need to sell its inventory or receive additional financing. Calculated by dividing current assets [AssetsC] minus [Inventory] by current liabilities [LiabilitiesC].
- Current Liabilities - [Balance Sheet] The current (short-term) portion of [Liabilities] includes obligations that are due to be paid to creditors within one year, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
- Total Liabilities - [Balance Sheet] Total liabilities are the sum of all possible claims against the company. Common examples are [Debt], [Payables], deferred revenues, issued bonds, warranties, and tax liabilities.
- Non-Current Liabilities - [Balance Sheet] The non-current (long-term) portion of [Liabilities] includes obligations that are due to be paid to creditors more than year in the future, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
Definition of Working Capital
[Calculation] The working capital represents the capital used in day-to-day operations. It is the difference between a company’s short-term assets [AssetsC] and current liabilities [LiabilitiesC].AssetsC - LiabilitesC
(=) Working Capital Working Capital for CUE BIOPHARMA INC is calculated as follows: AssetsC [ $ 93.56M ] - LiabilitesC [ $ 14.23M ]
(=) Working Capital [ $ 79.34M ] CUE - Working Capital, Last 5 years
$ 433K
Minimum
Mar 31, 2025
$ 79.34M
Maximum
Sep 30, 2020
$ 44.47M
Average
$ 53.19M
Median
Working Capital Benchmark AnalysisMarket
The chart above depicts the distribution of Working Capital for companies in the Total Stock Market. The average Working Capital of the companies is $ 96.5M with a standard deviation of $ 173.86M.
The following table provides additional summary stats:
Working Capital in the Market:
| filtered constituents | 2.78K |
|---|---|
| min | $ -465.2M |
| max | $ 607.04M |
| average | $ 96.5M |
| median | $ 32.21M |
| std | $ 173.86M |